COMMUNIQUÉS West-GlobeNewswire

Novavax to Host Conference Call to Discuss Third Quarter 2017 Financial Results on November 7, 2017
31/10/2017
GAITHERSBURG, Md., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its third quarter financial and operating results following the close of U.S. financial markets on Tuesday [...]
Les données provisoires de Vascular Dynamics sur MobiusHD présentées à la conférence TCT montrent des réductions significatives de la pression artérielle systolique ambulatoire à échéance de six mois
31/10/2017
La société a lancé un essai pilote du MobiusHD aux États-Unis et en Europe MOUNTAIN VIEW, Californie, le 31 octobre 2017 (GLOBE NEWSWIRE) - Vascular Dynamics, Inc., une société privée de dispositifs médicaux qui [...]
Oxford BioMedica notes the sBLA submission to FDA for Kymriah(TM) in adult patients with r/r DLBCL
31/10/2017
Oxford BioMedica notes the sBLA submission to FDA for Kymriah(TM) in adult patients with r/r DLBCL Oxford, UK - 31 October 2017 : Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE:OXB), a leading gene and [...]
New Analyses Reinforce Hemodynamic Benefits of Medtronic Evolut(TM) TAVR Platform in Intermediate Risk Aortic Stenosis Patients
31/10/2017
Presented at TCT, Evolut TAVR Platform Showcases Positive Clinical Outcomes in Patients Wanting to Return to More Active Lives DUBLIN and DENVER - October 31, 2017 - Medtronic plc (NYSE:MDT) today presented new clinical [...]
Novo Nordisk A/S - Share repurchase programme
31/10/2017
Bagsværd, Denmark, 31 October 2017 - On 9 August 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Minerva Neurosciences Names Dr. Justine Lalonde as Senior Vice President, Product Strategy
31/10/2017
WALTHAM, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
Immunocore to Present New Overall Survival Data in Metastatic Uveal Melanoma at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting
31/10/2017
PRESS RELEASE Immunocore to Present New Overall Survival Data in Metastatic Uveal Melanoma at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting (Oxford, UK and Conshohocken, US, 31 October 2017) [...]
ObsEva SA to Hold Third Quarter 2017 Financial Results and Business Update Call on November 14, 2017 and Present at Credit Suisse and Jefferies Investor Conferences in November
31/10/2017
Geneva, Switzerland and Boston, MA - October 31, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Sanofi : Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function in a Phase 3 Study of People with Severe Steroid-Dependent Asthma
31/10/2017
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function in a Phase 3 Study of People with Severe Steroid-Dependent Asthma First [...]
Sanofi : Le dupilumab a permis de réduire significativement le recours aux corticoïdes et les crises d'asthme, et d'améliorer la fonction respiratoire, dans une étude de phase 3 portant sur des pe...
31/10/2017
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE: SNY) Le dupilumab a permis de réduire significativement le recours aux corticoïdes et les crises d'asthme, et d'améliorer la fonction respiratoire, dans une [...]
Clinical Decision Support System (CDSS) Market Worth $1,500 Million by 2022: Acumen Research and Consulting
31/10/2017
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled " Clinical Decision Support System Market (Solutions: Integrated CDSS Solutions, Standalone CDSS [...]
Photocure ASA: Presentation of the third quarter 2017 results
31/10/2017
Photocure will present its third quarter report on Wednesday 8 November 2017 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will be Kjetil Hestdal, [...]
HOMEVI S.A.S. CONFIRMS DATE OF REDEMPTION OF ITS €608 MILLION 6.875% SENIOR SECURED NOTES DUE 2021 AND ITS €200 MILLION FLOATING RATE SENIOR SECURED NOTES DUE 2021
31/10/2017
Suresnes, October 31, 2017 - 11:00 am CET HomeVi S.A.S. ("HomeVi"), today confirms that it has deposited aggregate proceeds in a sufficient quantity to pay the redemption price for all of its outstanding €608,000,000 6. [...]
NANOBIOTIX leve 27,2 millions d'euros dans le cadre d'un placement d'actions ordinaires nouvelles
31/10/2017
NANOBIOTIX LEVE 27,2 MILLIONS D'EUROS DANS LE CADRE D'UN PLACEMENT D'ACTIONS ORDINAIRES NOUVELLES Les fonds ont été levés par construction accélérée d'un livre d'ordre annoncé le 30 octobre 2017 Paris, France, et [...]
NANOBIOTIX successfully completes approximately eur 27.2 million placement of new shares
31/10/2017
NANOBIOTIX SUCCESSFULLY COMPLETES APPROXIMATELY EUR 27.2 MILLION PLACEMENT OF NEW SHARES Funds raised via an accelerated book building offering announced on October 30, 2017 Paris, France and Cambridge, Massachusetts ( [...]
Verona Pharma to Announce Operational Update and Financial Results for the Third Quarter Ended September 30, 2017
31/10/2017
LONDON, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Immunocore to Present New Overall Survival Data in Metastatic Uveal Melanoma at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting
31/10/2017
PRESS RELEASE Immunocore to Present New Overall Survival Data in Metastatic Uveal Melanoma at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting (Oxford, UK and Conshohocken, US, 31 October 2017) [...]
Verona Pharma to Present at Two Upcoming Investor Conferences
31/10/2017
LONDON, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
DBV Technologies Reports September 30, 2017 Cash Position
31/10/2017
Press Release Montrouge, France, October 31, 2017 DBV Technologies Reports September 30, 2017 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced its cash and [...]

Pages